Hypophosphatasia: diagnosis and clinical signs - a dental surgeon perspective

被引:48
作者
Bloch-Zupan, Agnes [1 ,2 ,3 ,4 ]
机构
[1] Univ Strasbourg, Fac Chirurg Dent, Strasbourg, France
[2] Hop Univ Strasbourg, Pole Med & Chirurg Buccodent, Reference Ctr Orodental Manifestat Rare Dis, Ctr Reference Manifestat Odontol Malad Rares CRMR, Strasbourg, France
[3] Univ Strasbourg, IGBMC, INSERM, U964,CNRS,UMR7104, Illkirch Graffenstaden, France
[4] UCL, Eastman Dent Inst, London, England
关键词
ENZYME-REPLACEMENT THERAPY; ALKALINE-PHOSPHATASE; MURINE HYPOPHOSPHATASIA; INORGANIC PYROPHOSPHATE; ORAL MANIFESTATIONS; IN-UTERO; PHENOTYPE; DISEASE; CHILDREN; SKELETAL;
D O I
10.1111/ipd.12232
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
BackgroundHypophosphatasia (HPP) is a rare inherited metabolic disease in which mutations in the ALPL gene (encoding tissue-nonspecific alkaline phosphatase) result in varying degrees of enzyme deficiency. HPP manifests in a spectrum of symptoms, including early primary tooth loss (root intact) and alveolar bone mineralisation defects. ObjectiveTo provide an overview of HPP for dental professionals to help recognise and differentially diagnose patients for appropriate referral to a specialist team. MethodsA non-systematic review of publications on HPP was performed. ResultsDifferent forms of HPP are described, along with characteristic symptoms and laboratory findings. Diagnosis is challenging due to the rareness and variable presentation of symptoms. Low alkaline phosphatase levels are a signature of HPP, but reference ranges vary according to gender and age. Key features are defined and management strategies discussed, focusing on enzyme replacement therapy. Finally, a patient registry aimed at better defining the prevalence of HPP and raising awareness is described. ConclusionsHPP is a rare disease with a wide spectrum of manifestations, with orodental symptoms featuring prominently in the natural history. Dental professionals may be positioned at the beginning of the diagnostic pathway; thus, recognition of HPP features for timely referral and optimal disease management is important.
引用
收藏
页码:426 / 438
页数:13
相关论文
共 62 条
  • [21] Kishnani PS, 2015, BONE ABSTRACTS, V4, pP154
  • [22] Leung ECW, 2013, JIMD REP, V11, P73, DOI 10.1007/8904_2013_224
  • [23] Vitamin D and tissue non-specific alkaline phosphatase in dental cells
    Lezot, Frederic
    Descroix, Vianney
    Hotton, Dominique
    Mauro, Nicole
    Kato, Shigeaki
    Berdal, Ariane
    [J]. EUROPEAN JOURNAL OF ORAL SCIENCES, 2006, 114 : 178 - 182
  • [24] Ludlow J, 2012, J AM DENT ASSOC, V143, P899
  • [25] Prosthodontic rehabilitation of hypophosphatasia using dental implants: a review of the literature and two case reports
    Lynch, C. D.
    Ziada, H. M.
    Buckley, L. A.
    O'Sullivan, V. R.
    Aherne, T.
    Aherne, S.
    [J]. JOURNAL OF ORAL REHABILITATION, 2009, 36 (06) : 462 - 468
  • [26] Malik Sangeeta, 2015, J Oral Maxillofac Pathol, V19, P110, DOI 10.4103/0973-029X.157220
  • [27] Mallya Sanjay M, 2015, J Calif Dent Assoc, V43, P512
  • [28] Novel ALPL genetic alteration associated with an odontohypophosphatasia phenotype
    Martins, Luciane
    Rodrigues, Thaisangela L.
    Ribeiro, Mariana Martins
    Saito, Miki Taketomi
    Oliveira Giorgetti, Ana Paula
    Casati, Marcio Z.
    Sallum, Enilson A.
    Foster, Brian L.
    Somerman, Martha J.
    Nociti, Francisco H., Jr.
    [J]. BONE, 2013, 56 (02) : 390 - 397
  • [29] Clinical and Radiographic Findings in Adults With Persistent Hypophosphatasemia
    McKiernan, Fergus Eoin
    Berg, Richard L.
    Fuehrer, Jay
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 (07) : 1651 - 1660
  • [30] Enzyme replacement therapy for murine hypophosphatasia
    Millan, Jose Luis
    Narisawa, Sonoko
    Lemire, Isabelle
    Loisel, Thomas P.
    Boileau, Guy
    Leonard, Pierre
    Gramatikova, Svetlana
    Terkeltaub, Robert
    Camacho, Nancy Pleshko
    McKee, Marc D.
    Crine, Philippe
    Whyte, Michael P.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 (06) : 777 - 787